Literature DB >> 35462593

Overall Survival Advantage of Omentum Preservation Over Omentectomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.

Meng Kong1,2, Hongyuan Chen1,2, Rong Zhang3, Hongguang Sheng1,2, Leping Li4,5.   

Abstract

BACKGROUND: Since 1910, omentectomy has been an essential component of radical gastrectomy for advanced gastric cancer. However, researchers have recently questioned the benefit of omentectomy in radical gastrectomy. The aim of this meta-analysis was to compare omentectomy and omentum preservation in gastrectomy for advanced gastric cancer in terms of survival outcomes and short-term outcomes.
METHODS: The PubMed, Embase, Web of Science, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases were searched. Studies that compared omentum preservation with omentectomy were included. Overall survival (OS) and relapse-free survival (RFS) were analyzed as primary outcomes.
RESULTS: Of 3509 records screened, one randomized clinical trial and five propensity-score matched retrospective studies with 1661 patients were selected. Omentum preservation was associated with improved OS (hazard ratio [HR] = 0.757, 95% confidence interval [CI] = 0.603-0.950, P = 0.016, I2 = 0%), but not with improved RFS (HR = 0.821, 95% CI = 0.668-1.009, P = 0.060, I2 = 9%) compared with omentectomy for advanced gastric cancer. Furthermore, less blood loss and shorter operation time were found in the omentum preservation group than in the omentectomy group. Additionally, the rate of peritoneal recurrence, the number of harvested lymph nodes, and the incidences of postoperative complications and ileus were comparable in the two groups.
CONCLUSIONS: Basing on the current literature, gastrectomy with omentum preservation was associated with improved OS and short-term outcomes compared with omentectomy for advanced gastric cancer. Further randomized trials are required to confirm the survival benefit of omentum-preserving gastrectomy.
© 2022. The Author(s) under exclusive licence to Société Internationale de Chirurgie.

Entities:  

Mesh:

Year:  2022        PMID: 35462593     DOI: 10.1007/s00268-022-06562-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.282


  7 in total

1.  The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.

Authors:  Matthew J Page; Joanne E McKenzie; Patrick M Bossuyt; Isabelle Boutron; Tammy C Hoffmann; Cynthia D Mulrow; Larissa Shamseer; Jennifer M Tetzlaff; Elie A Akl; Sue E Brennan; Roger Chou; Julie Glanville; Jeremy M Grimshaw; Asbjørn Hróbjartsson; Manoj M Lalu; Tianjing Li; Elizabeth W Loder; Evan Mayo-Wilson; Steve McDonald; Luke A McGuinness; Lesley A Stewart; James Thomas; Andrea C Tricco; Vivian A Welch; Penny Whiting; David Moher
Journal:  Int J Surg       Date:  2021-03-29       Impact factor: 6.071

2.  Short-Term Outcomes from a Randomized Screening Phase II Non-inferiority Trial Comparing Omentectomy and Omentum Preservation for Locally Advanced Gastric Cancer: the TOP-G Trial.

Authors:  Hitoshi Murakami; Takanobu Yamada; Masataka Taguri; Shinichi Hasegawa; Takeharu Yamanaka; Yasushi Rino; Hiroyuki Mushiake; Takashi Oshima; Hiroshi Matsukawa; Kazuyuki Tani; Yoshihiro Suzuki; Yukihiro Ozawa; Hiroyasu Tanabe; Tomohiko Osaragi; Tsutomu Sato; Hiroshi Tamagawa; Norio Yukawa; Takaki Yoshikawa; Toshio Imada; Munetaka Masuda; Yuji Yamamoto
Journal:  World J Surg       Date:  2021-02-10       Impact factor: 3.352

3.  Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice.

Authors:  A Hagiwara; T Takahashi; K Sawai; H Taniguchi; M Shimotsuma; S Okano; C Sakakura; H Tsujimoto; K Osaki; S Sasaki
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

4.  Morphological study and comprehensive cellular constituents of milky spots in the human omentum.

Authors:  Jiu-Yang Liu; Jing-Ping Yuan; Xia-Fei Geng; Ai-Ping Qu; Yan Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Omentum-preserving gastrectomy for early gastric cancer.

Authors:  Tae Kyung Ha; Ji Yeong An; Ho Geun Youn; Jae Hyung Noh; Tae Sung Sohn; Sung Kim
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

6.  Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-institutional Dataset.

Authors:  Yuki Ito; Mitsuro Kanda; Seiji Ito; Yoshinari Mochizuki; Hitoshi Teramoto; Kiyoshi Ishigure; Toshifumi Murai; Takahiro Asada; Akiharu Ishiyama; Hidenobu Matsushita; Chie Tanaka; Daisuke Kobayashi; Michitaka Fujiwara; Kenta Murotani; Yasuhiro Kodera
Journal:  World J Surg       Date:  2019-03       Impact factor: 3.352

7.  Robotic single-site versus multi-port myomectomy: a case-control study.

Authors:  So Hyun Ahn; Joo Hyun Park; Hye Rim Kim; SiHyun Cho; Myeongjee Lee; Seok Kyo Seo; Young Sik Choi; Byung Seok Lee
Journal:  BMC Surg       Date:  2021-05-27       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.